Atyr1923 5.0 mg/kg    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
84Sarcoidosis1

84. Sarcoidosis    [ 143 clinical trials,   221 drugs,   (DrugBank: 79 drugs),   82 drug target genes,   165 drug target pathways]
Searched query = "Sarcoidosis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 143 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03824392
(ClinicalTrials.gov)
January 29, 201928/1/2019Study of Intravenous ATYR1923 for Pulmonary SarcoidosisA Randomized, Double-Blind, Placebo-Controlled Multiple Ascending Dose Study of Intravenous ATYR1923 in Patients With Pulmonary SarcoidosisPulmonary SarcoidosisBiological: ATYR1923 1.0 mg/kg or placebo;Biological: ATYR1923 3.0 mg/kg or placebo;Biological: ATYR1923 5.0 mg/kg or placeboaTyr Pharma, Inc.Foundation for Sarcoidosis ResearchRecruiting18 Years70 YearsAll36Phase 1;Phase 2United States